BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29193961)

  • 1. Chemical Proteomics Reveals Soluble Epoxide Hydrolase as a Therapeutic Target for Ocular Neovascularization.
    Sulaiman RS; Park B; Sheik Pran Babu SP; Si Y; Kharwadkar R; Mitter SK; Lee B; Sun W; Qi X; Boulton ME; Meroueh SO; Fei X; Seo SY; Corson TW
    ACS Chem Biol; 2018 Jan; 13(1):45-52. PubMed ID: 29193961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased Expression of Soluble Epoxide Hydrolase Suppresses Murine Choroidal Neovascularization.
    Park B; Sardar Pasha SPB; Sishtla KL; Hartman GD; Qi X; Boulton ME; Corson TW
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy.
    Sulaiman RS; Merrigan S; Quigley J; Qi X; Lee B; Boulton ME; Kennedy B; Seo SY; Corson TW
    Sci Rep; 2016 May; 6():25509. PubMed ID: 27148944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450 monooxygenase lipid metabolites are significant second messengers in the resolution of choroidal neovascularization.
    Hasegawa E; Inafuku S; Mulki L; Okunuki Y; Yanai R; Smith KE; Kim CB; Klokman G; Bielenberg DR; Puli N; Falck JR; Husain D; Miller JW; Edin ML; Zeldin DC; Lee KSS; Hammock BD; Schunck WH; Connor KM
    Proc Natl Acad Sci U S A; 2017 Sep; 114(36):E7545-E7553. PubMed ID: 28827330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the binding mode of 1, 3, 4-oxadiazole derivatives as amide-based inhibitors for soluble epoxide hydrolase (sEH) by molecular docking and MM-GBSA.
    Karami L; Saboury AA; Rezaee E; Tabatabai SA
    Eur Biophys J; 2017 Jul; 46(5):445-459. PubMed ID: 27928588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small Molecule Soluble Epoxide Hydrolase Inhibitors in Multitarget and Combination Therapies for Inflammation and Cancer.
    Das Mahapatra A; Choubey R; Datta B
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33255197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain.
    Lee KSS; Ng JC; Yang J; Hwang SH; Morisseau C; Wagner K; Hammock BD
    Bioorg Med Chem; 2020 Nov; 28(22):115735. PubMed ID: 33007552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of hydrolase and phosphatase domains in soluble epoxide hydrolase to vascular endothelial growth factor expression and cell growth.
    Oguro A; Sakamoto K; Suzuki S; Imaoka S
    Biol Pharm Bull; 2009 Dec; 32(12):1962-7. PubMed ID: 19952412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Effects of PPARα Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular Degeneration.
    Qiu F; Matlock G; Chen Q; Zhou K; Du Y; Wang X; Ma JX
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5065-5075. PubMed ID: 28980001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress.
    Ren Q; Ma M; Ishima T; Morisseau C; Yang J; Wagner KM; Zhang JC; Yang C; Yao W; Dong C; Han M; Hammock BD; Hashimoto K
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1944-52. PubMed ID: 26976569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical application of a G-Quartet aptamer targeting nucleolin attenuates choroidal neovascularization in a model of age-related macular degeneration.
    Leaderer D; Cashman SM; Kumar-Singh R
    Exp Eye Res; 2015 Nov; 140():171-178. PubMed ID: 26368850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble Epoxide Hydrolase Inhibition for Ocular Diseases: Vision for the Future.
    Park B; Corson TW
    Front Pharmacol; 2019; 10():95. PubMed ID: 30792659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brivanib, a multitargeted small-molecule tyrosine kinase inhibitor, suppresses laser-induced CNV in a mouse model of neovascular AMD.
    Li L; Zhu M; Wu W; Qin B; Gu J; Tu Y; Chen J; Liu D; Shi Y; Liu X; Sang A; Ding D
    J Cell Physiol; 2020 Feb; 235(2):1259-1273. PubMed ID: 31270802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural soluble epoxide hydrolase inhibitors from Alisma orientale and their potential mechanism with soluble epoxide hydrolase.
    Zhao WY; Zhang XY; Zhou MR; Tian XG; Lv X; Zhang HL; Deng S; Zhang BJ; Sun CP; Ma XC
    Int J Biol Macromol; 2021 Jul; 183():811-817. PubMed ID: 33957203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human soluble epoxide hydrolase: structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids.
    Gomez GA; Morisseau C; Hammock BD; Christianson DW
    Protein Sci; 2006 Jan; 15(1):58-64. PubMed ID: 16322563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel drug candidates for inhibition of soluble epoxide hydrolase of arachidonic acid cascade pathway implicated in atherosclerosis.
    Gurung AB; Mayengbam B; Bhattacharjee A
    Comput Biol Chem; 2018 Jun; 74():1-11. PubMed ID: 29522918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of soluble epoxide hydrolase by fulvestrant and sulfoxides.
    Morisseau C; Pakhomova S; Hwang SH; Newcomer ME; Hammock BD
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3818-21. PubMed ID: 23684894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural soluble epoxide hydrolase inhibitors from Inula britanica and their potential interactions with soluble epoxide hydrolase: Insight from inhibition kinetics and molecular dynamics.
    Zhao WY; Yan JJ; Zhang M; Wang C; Feng L; Lv X; Huo XK; Sun CP; Chen LX; Ma XC
    Chem Biol Interact; 2021 Aug; 345():109571. PubMed ID: 34217688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing ligand-binding modes and binding mechanisms of benzoxazole-based amide inhibitors with soluble epoxide hydrolase by molecular docking and molecular dynamics simulation.
    Chen H; Zhang Y; Li L; Han JG
    J Phys Chem B; 2012 Aug; 116(34):10219-33. PubMed ID: 22857012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase.
    Kodani SD; Bhakta S; Hwang SH; Pakhomova S; Newcomer ME; Morisseau C; Hammock BD
    Bioorg Med Chem Lett; 2018 Feb; 28(4):762-768. PubMed ID: 29366648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.